
Imcivree Coupons & Savings Card – Discount Prices from $3825.63
My prescription
Edit
1ML of 10MG/ML, Imcivree (1 Vial)
Select pharmacy

Walgreens
$3825.63
COUPON PRICE
Albertsons
$3826.08
COUPON PRICE
Walmart
$3911.18
COUPON PRICEImcivree savings card
Show this card to your pharmacist
Walgreens
$3825.63
BIN
ID
PCN
GRP
015995
LHKPY242025
GDC
DR33
Powered by
Related melanocortin receptor agonists prescriptions
More prescriptions for weight loss
Related melanocortin receptor agonists prescriptions
More prescriptions for weight loss
Price history for Imcivree
1 Vial, 1ML of 10MG/ML
Average retail price for Imcivree
Average SaveHealth price for Imcivree
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Imcivree dosage forms
Dosage Quantity Price from Per unit 1ML of 10MG/ML 1 Vial $3911.18 $3911.18 1ML of 10MG/ML 2 Vials $7822.41 $3911.20 1ML of 10MG/ML 3 Vials $11729.86 $3909.95
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 1ML of 10MG/ML | 1 Vial | $3911.18 | $3911.18 |
| 1ML of 10MG/ML | 2 Vials | $7822.41 | $3911.20 |
| 1ML of 10MG/ML | 3 Vials | $11729.86 | $3909.95 |
Is imcivree the same as wegovy?
Imcivree and Wegovy are not the same. Imcivree (setmelanotide) is used for chronic weight management in patients with certain rare genetic conditions, while Wegovy (semaglutide) is used for chronic weight management in adults with obesity or overweight with at least one weight-related condition. They have different active ingredients and mechanisms of action.
What is the use of Imcivree?
Imcivree is used to treat chronic weight management in patients with obesity due to certain genetic conditions, specifically those related to POMC, PCSK1, or LEPR deficiencies. It works by targeting the melanocortin-4 receptor pathway, which is involved in regulating hunger and energy expenditure.
Is Imcivree approved by the FDA?
Yes, Imcivree (setmelanotide) is approved by the FDA. It is indicated for chronic weight management in patients with certain rare genetic conditions that lead to obesity.
What are the criteria for Imcivree?
Imcivree (setmelanotide) is indicated for chronic weight management in patients with obesity due to certain genetic conditions. The criteria for its use include:1. Genetic Confirmation: The patient must have a confirmed diagnosis of obesity due to POMC, PCSK1, or LEPR deficiency, or Bardet-Biedl syndrome, as determined by genetic testing.2. Age Requirement: It is approved for use in patients aged 6 years and older.3. Weight Management: It is intended for chronic weight management and should be part of a comprehensive weight management program that includes dietary and lifestyle modifications.4. Monitoring: Regular monitoring of weight and other health parameters is necessary to assess the effectiveness and safety of the treatment.These criteria ensure that Imcivree is used appropriately in patients who are most likely to benefit from its effects.
How much weight can you lose on Imcivree?
The amount of weight loss on Imcivree (setmelanotide) can vary depending on the individual and the specific genetic condition being treated. In clinical trials, patients with certain genetic obesity disorders experienced significant weight loss. For example, individuals with POMC or LEPR deficiency had an average weight loss of around 10% to 25% of their initial body weight. However, results can differ based on individual factors and adherence to the treatment plan. It is important for patients to discuss their specific situation and potential outcomes with their healthcare provider.
